Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide MDI vs Budesonide DPI in Asthma (China, Phase IV)
CTR20170291Phase 4Completed
- Sponsor
- Anhui Wellman Pharmaceutical
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ciclesonide in asthma, sponsored by Anhui Wellman Pharmaceutical. Started Mar 2017; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20170291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170291.